Cowen and Company’s Halozyme HALO Stock Holding History

Cowen and Company’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,000	Closed	-$25K	–	627
2021 Q1	$25K	Buy	+25,000	New	+$1.14M	﹤0.01%	442

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Cowen and Company's HALO Position: Q1 2024 in Review

Cowen and Company sold out of Halozyme (HALO) in Q1 2024, closing a stake of 54,034 shares — an estimated $2M sold.

Cowen and Company first reported a position in HALO in Q1 2021 and held it in 3 quarters. The position peaked at $2M in Q4 2023. 414 funds tracked by Wall St. Rank hold HALO as of Q1 2024.

Cowen and Company reported no remaining Halozyme position as of Q1 2024 after selling out during the quarter.
Cowen and Company sold 54,034 Halozyme shares in Q1 2024, an estimated $2M.
Cowen and Company first reported a position in Halozyme in Q1 2021 and held it in 3 quarters.
Cowen and Company's Halozyme position peaked at $2M in Q4 2023.
414 funds tracked by Wall St. Rank held Halozyme as of Q1 2024.

Based on Cowen and Company's 13F filing for Q1 2024, filed 3 May 2024.